William Klugh Kennedy, Megan Leloux, Eric C Kutscher, Paul L Price, Anne E Morstad, Ryan M Carnahan
Mercer University College of Pharmacy and School of Medicine-Savannah Campus, Memorial University Medical Center, 4700 Waters Avenue, Savannah, GA 31403, USA. Kennedy_wk@mercer.edu
Expert opinion on drug metabolism & toxicology 2010 MarAlcohol abuse and dependence are major causes of morbidity and mortality and come with a high societal cost. The illness is notoriously difficult to treat and relapse is a common occurrence. Acamprosate represents an effective addition to the treatment options available for alcohol dependence with a novel mechanism of action. We review the published acamprosate literature focusing on major and recent comparative clinical trials and meta-analyses. We included all studies found in National Library of Medicine's PubMed database searching on Mesh term: acamprosate excluded animal studies excluding non-English publications, and focusing on efficacy/effectiveness studies. Additionally, we discuss background information on alcohol dependence and acamprosate's putative mechanism of action. Safety and tolerability data are also presented. The reader will gain a better understanding of the role of acamprosate in the treatment of alcohol dependence and find a useful synopsis of the more recently published literature evaluating acamprosate's effectiveness based on what are not always identically defined primary study outcomes. Acamprosate is safe and effective in the maintenance of abstinence from alcohol use/abuse and is most commonly used in combination with nonpharmacologic therapeutic modalities. The effect size ranged from 1.3 to 2 for most of the studies included in this review.
William Klugh Kennedy, Megan Leloux, Eric C Kutscher, Paul L Price, Anne E Morstad, Ryan M Carnahan. Acamprosate. Expert opinion on drug metabolism & toxicology. 2010 Mar;6(3):363-80
PMID: 20163323
View Full Text